Skip to content

A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients.

A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-007322-19-GB
Enrollment
58
Registered
2010-11-23
Start date
2009-07-07
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain experienced by patients with pre-existing burns presenting to the burns outpatients unit requiring two or more dressing changes

Interventions

Trade Name: Remifentanil Product Name: Remifentanil Pharmaceutical Form: Powder for solution for infusion Trade Name: Oramorph Product Name: Oramorph Pharmaceutical Form: Oral solution

Sponsors

Queen Victoria Hospital NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Outpatients requiring two or more dressing changes for burns who would normally be considered appropriate for oral morphine analgesia. • ASA 1 and 2 patients over the age of 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: • Patients unable to use the hand control of the PCA device • Patients who are unable to give full consent or do not agree to participate in the trial • Hypersensitivity or history of serious adverse reactions to remifentanil or morphine • Surgical or anaesthetic objections • Pregnancy

Design outcomes

Primary

MeasureTime frame
Main Objective: To determine whether remifentanil PCA or oral morphine provides more effective analgesia for out-patient dressing changes in the burns unit. ;Secondary Objective: To determine if burns patients prefer traditional analgesia or remifentanil analgesia for dressing changes ;Primary end point(s): Maximum visual analogue scale (VAS) pain score during the dressing change procedure.

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026